当前位置： SCI文献检索 > MINERVA MEDICA期刊下所有文献 > Supplementation with Robuvit® in post-traumatic stress disorders associated to high oxidative stress.

Supplementation with Robuvit® in post-traumatic stress disorders associated to high oxidative stress.

Abstract：

BACKGROUND:Post-traumatic stress disorder (PTSD) is associated to recurrent, obsessive recollection of severe traumatic events. This condition is still not completely understood. Elective treatment of PTSD is psychotherapy. Standardized supplements, used for improving chronic fatigue syndrome (i.e. Robuvit®, Horphag Research Ltd) can also be used to control some of the symptoms associated to PTSD, as well as to control the associated increased oxidative stress, present in many of these patients. The aim of this open registry was to evaluate the effects of supplementary Robuvit® 300 mg/day, added to standard management (SM), in subjects with PTSD over a period of 4 weeks, both on the psychological and the inflammatory level. METHODS:Otherwise healthy individuals with a diagnosis of PTSD were included in this registry. A clear main traumatic event occurred with different modalities in all subjects during or just after major earthquakes in Central Italy. SM included exposure therapy and psychotherapy. Supportive psychotherapy was used in all affected subjects. Subjects autonomously decided which group to enter (either SM or SM + Robuvit®), without any pre-defined group allocation or randomization. No placebo was used. RESULTS:The two groups were comparable: 18 subjects (11 females; age range 25-49) were included in the SM group, and 16 subjects (8 females; age range 26-52) using SM in combination with Robuvit® supplementation. BMI of all subjects was below 25 kg/m2. After 4 weeks, the percentages of subjects with recurrent memories and dreams, transient walking-dissociative states and reactive flashbacks/hallucinations, alarm reactions and intense emotional distress, emotional numbness, social disinterest and detachment were significantly lower in the subjects treated with Robuvit® (P<0.05%). Sleeping problems, irritability, and fatigue were also significantly reduced with supplementation. CONCLUSIONS:The results of our preliminary, pilot registry show that symptoms of PTSD as well as the high oxidative stress-related to the condition can be controlled and improved using Robuvit® as a supplementary management. The improvement with Robuvit® is faster and larger than that seen with standard management only. Supplementation is safe and well tolerated and may represent an important option in PTSD treatment.

journal_name

Minerva Med

journal_title

Minerva medica

authors

Belcaro G,Luzzi R,Hosoi M,Dugall M,Cesarone MR

doi

10.23736/S0026-4806.18.05573-8

subject

Has Abstract

pub_date

2018-10-01 00:00:00

pages

363-368

issue

eissn

0026-4806

issn

1827-1669

pii

S0026-4806.18.05573-8

journal_volume

109

pub_type

临床试验,杂志文章

在线工具

Supplementation with Robuvit® in post-traumatic stress disorders associated to high oxidative stress.